BCAXBicara Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 12313
Ticker: BCAX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-09-13
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BCAX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,629,839,364.42
Shares outstanding (class): 65,703,866
Shares outstanding (weighted): 66,172,934
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 103
Location: BOSTON, MA
Homepage: https://www.bicara.com
Description: Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.

Market cap and share counts drift.

Funds holding this security

85 funds · 88 positions · $194.85M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$43.39M	0.54%	2,181,694 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$27.28M	0.00%	1,371,353 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$23.80M	0.55%	1,196,337 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$15.52M	0.02%	780,131 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$14.02M	0.15%	705,031 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$13.96M	0.19%	701,643 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$12.78M	0.12%	642,514 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$7.08M	0.01%	356,186 NS	FIGI
T. Rowe Price Integrated U.S. Small-Cap Growth … T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.	—	$5.72M	0.07%	287,800 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$5.05M	0.04%	253,669 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$4.71M	0.06%	236,865 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$2.60M	0.06%	130,808 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$1.05M	0.10%	52,958 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.04M	0.02%	52,448 NS	FIGI
JPMorgan Small Cap Value Fund JPMorgan Trust II	—	$1.01M	0.09%	50,882 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBCAX
FIGI_COMPOSITEBBG00Z15DGK7
FIGI_SHARE_CLASSBBG00Z15DGL6
CIK0002023658
ISINUS0554771032
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Bicara Therapeutics is a biopharmaceutical company developing therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.